Sa1047 The Real Life Experience With the Development and Management of Anemia in the Era of Protease Inhibitors for Chronic Hepatitis C Infection

2013 ◽  
Vol 144 (5) ◽  
pp. S-981
Author(s):  
Gurshawn Singh ◽  
Danny Issa ◽  
Brigette Bevly ◽  
Ibrahim A. Hanouneh ◽  
Rocio Lopez ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Chronic Hepatitis C ◽  
Life Experience ◽  
Real Life ◽  
Hepatitis C Infection ◽  
The Real ◽  
Development And Management

Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort

2020 ◽  
Vol 27 (10) ◽  
pp. 964-973
Author(s):  
Victor Lédinghen ◽  
Clovis Lusivika‐Nzinga ◽  
Jean‐Pierre Bronowicki ◽  
Fabien Zoulim ◽  
Dominique Larrey ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Life Experience ◽  
Real Life ◽  
Hepatitis C Infection ◽  
Genotype 2

scholarly journals Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population

2016 ◽  
Vol 4 ◽  
pp. 133-137
Author(s):  
Anna Piekarska ◽  
Ewa Koślińska-Berkan ◽  
Kamila Wójcik ◽  
Anna Skubała ◽  
Maciej Jabłkowski ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Chronic Hepatitis C ◽  
First Generation ◽  
Real Life ◽  
Direct Costs ◽  
Hepatitis C Treatment
Sign in / Sign up

Export Citation Format

Share Document